TY - JOUR
T1 - Lymphomas involving the breast
T2 - A study of 106 cases comparing localized and disseminated neoplasms
AU - Talwalkar, Sameer S.
AU - Miranda, Roberto N.
AU - Valbuena, Jose R.
AU - Routbort, Mark J.
AU - Martin, Alvin W.
AU - Medeiros, L. Jeffrey
N1 - Copyright:
Copyright 2012 Elsevier B.V., All rights reserved.
PY - 2008/9
Y1 - 2008/9
N2 - Lymphomas involving the breast account for approximately 2% of extranodal and <1% of all non-Hodgkin lymphomas. Our aim in this study was to classify breast lymphomas using the World Health Organization classification and then compare this classification with clinical, histologic, and radiologic findings as well as survival. The study group included 106 patients with breast lymphoma (105 women and 1 man). The neoplasms were divided into 2 groups based on extent of disease at initial diagnosis: localized disease (n=50) and disseminated disease (n=56). The follow-up period ranged from 4 to 252 months (median, 49 mo). Almost all (97%) patients presented with a palpable breast mass or masses. In the localized group, diffuse large B-cell lymphoma (DLBCL) was most frequent (n=32, 64%). In the disseminated group, follicular lymphoma was most frequent and exclusive to this group (P=0.0004). Mucosa-associated lymphoid tissue lymphomas occurred in both groups without a significant difference in frequency. A variety of other types of B-cell and T-cell non-Hodgkin lymphomas and classical Hodgkin lymphoma involved the breast at much lower frequency; most of these neoplasms involved the breast as part of dissemnated disease. The clinical presentation correlated with radiologic findings: localized lymphomas presented as solitary masses, whereas disseminated lymphomas commonly presented as multifocal masses. There was a significant difference in the disease-free survival between patients with localized and disseminated DLBCL (P=0.003). In the disseminated group, patients with DLBCL had a worse disease-free survival compared with patients with mucosa-associated lymphoid tissue lymphoma or follicular lymphoma (P=0.01).
AB - Lymphomas involving the breast account for approximately 2% of extranodal and <1% of all non-Hodgkin lymphomas. Our aim in this study was to classify breast lymphomas using the World Health Organization classification and then compare this classification with clinical, histologic, and radiologic findings as well as survival. The study group included 106 patients with breast lymphoma (105 women and 1 man). The neoplasms were divided into 2 groups based on extent of disease at initial diagnosis: localized disease (n=50) and disseminated disease (n=56). The follow-up period ranged from 4 to 252 months (median, 49 mo). Almost all (97%) patients presented with a palpable breast mass or masses. In the localized group, diffuse large B-cell lymphoma (DLBCL) was most frequent (n=32, 64%). In the disseminated group, follicular lymphoma was most frequent and exclusive to this group (P=0.0004). Mucosa-associated lymphoid tissue lymphomas occurred in both groups without a significant difference in frequency. A variety of other types of B-cell and T-cell non-Hodgkin lymphomas and classical Hodgkin lymphoma involved the breast at much lower frequency; most of these neoplasms involved the breast as part of dissemnated disease. The clinical presentation correlated with radiologic findings: localized lymphomas presented as solitary masses, whereas disseminated lymphomas commonly presented as multifocal masses. There was a significant difference in the disease-free survival between patients with localized and disseminated DLBCL (P=0.003). In the disseminated group, patients with DLBCL had a worse disease-free survival compared with patients with mucosa-associated lymphoid tissue lymphoma or follicular lymphoma (P=0.01).
KW - Breast
KW - Difiuse large B-cell lymphoma
KW - Immunohistochemistry
KW - MALT-lymphoma
KW - Non-Hodgkin lymphoma
UR - http://www.scopus.com/inward/record.url?scp=52149087207&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=52149087207&partnerID=8YFLogxK
U2 - 10.1097/PAS.0b013e318165eb50
DO - 10.1097/PAS.0b013e318165eb50
M3 - Article
C2 - 18636016
AN - SCOPUS:52149087207
SN - 0147-5185
VL - 32
SP - 1299
EP - 1309
JO - American Journal of Surgical Pathology
JF - American Journal of Surgical Pathology
IS - 9
ER -